CVM Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
5.6M
+4.3%
5.3M
-0.8%
5.4M
-11.0%
6.0M
+9.9%
5.5M
R&D
3.6M
-3.1%
3.8M
+2.4%
3.7M
-0.7%
3.7M
-1.0%
3.7M
SG&A
1.9M
+22.3%
1.6M
-7.8%
1.7M
-27.4%
2.3M
+33.3%
1.7M
Operating Income
-5557285
-4.3%
-5326009
+0.8%
-5368806
+11.0%
-6033332
-9.9%
-5488883
EBITDA
-4610915
-5.5%
-4369608
+0.8%
-4404384
+13.2%
-5072482
-12.0%
-4529874
Net Income
-5667525
-3.7%
-5465751
+0.1%
-5469446
+10.4%
-6100900
-7.7%
-5664704
EPS (Basic)
$-0.47
+29.9%
$-0.67
+1.5%
$-0.68
+20.9%
$-0.86
+36.8%
$-1.36
EPS (Diluted)
$-0.47
+29.9%
$-0.67
+1.5%
$-0.68
+20.9%
$-0.86
+36.8%
$-1.36
Shares (Diluted)
12.1M
+48.9%
8.1M
+1.5%
8.0M
+13.3%
7.1M
+70.5%
4.2M
Cel-Sci (CVM) โ€” Financials